Maven Securities’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,800
Closed -$772K 520
2025
Q2
$772K Buy
+2,800
New +$761K 0.02% 498
2025
Q1
Sell
-2,300
Closed -$534K 819
2024
Q4
$534K Buy
+2,300
New +$529K 0.01% 567
2024
Q3
Sell
-1,100
Closed -$216K 926
2024
Q2
$216K Buy
+1,100
New +$227K ﹤0.01% 866
2023
Q4
Sell
-1,000
Closed -$200K 961
2023
Q3
$200K Sell
1,000
-4,800
-83% -$954K ﹤0.01% 1046
2023
Q2
$1.07M Buy
5,800
+1,000
+21% +$185K 0.02% 423
2023
Q1
$919K Buy
4,800
+3,600
+300% +$651K 0.02% 488
2022
Q4
$202K Sell
1,200
-4,800
-80% -$834K ﹤0.01% 783
2022
Q3
$1.06M Buy
+6,000
New +$1.19M 0.02% 515
2022
Q2
Sell
-800
Closed -$190K 918
2022
Q1
$190K Sell
800
-3,000
-79% -$705K 0.01% 796
2021
Q4
$868K Buy
3,800
+1,400
+58% +$308K 0.02% 393
2021
Q3
$464K Sell
2,400
-4,300
-64% -$871K 0.02% 676
2021
Q2
$1.43M Buy
6,700
+5,700
+570% +$1.2M 0.06% 322
2021
Q1
$204K Buy
+1,000
New +$197K 0.01% 917
2020
Q4
Sell
-1,300
Closed -$218K 611
2020
Q3
$218K Buy
+1,300
New +$219K 0.02% 542
2019
Q4
Sell
-500
Closed -$106K 371
2019
Q3
$106K Buy
+500
New +$104K 0.03% 192

Other funds holding CME

Maven Securities's CME Position: Q3 2025 in Review

Maven Securities sold out of CME Group (CME) in Q3 2025, closing a stake of 3,918 shares — an estimated $1.08M sold.

Maven Securities first reported a position in CME in Q4 2016 and held it in 32 quarters. The position peaked at $3.78M in Q3 2019. 1,653 funds tracked by Wall St. Rank hold CME as of Q3 2025.

  • Maven Securities reported no remaining CME Group position as of Q3 2025 after selling out during the quarter.
  • Maven Securities sold 3,918 CME Group shares in Q3 2025, an estimated $1.08M.
  • Maven Securities first reported a position in CME Group in Q4 2016 and held it in 32 quarters.
  • Maven Securities's CME Group position peaked at $3.78M in Q3 2019.
  • 1,653 funds tracked by Wall St. Rank held CME Group as of Q3 2025.

Based on Maven Securities's 13F filing for Q3 2025, filed 20 Nov 2025.